| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Theodora Psaltopoulou | Q47251608 |
| P2093 | author name string | Maria Gazouli | |
| Anna Vaiopoulou | |||
| Georgios Karamanolis | |||
| George Karatzias | |||
| P2860 | cites work | Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia | Q24539231 |
| The enduring effects of abuse and related adverse experiences in childhood. A convergence of evidence from neurobiology and epidemiology | Q24631680 | ||
| Diet and the epigenetic (re)programming of phenotypic differences in behavior | Q24634401 | ||
| Epigenetic principles and mechanisms underlying nervous system functions in health and disease | Q24657549 | ||
| Genetic Risk Factors for Post-Infectious Irritable Bowel Syndrome Following a Waterborne Outbreak of Gastroenteritis | Q61536312 | ||
| [Recent insights into the pathogenesis of abdominal symptoms in functional bowel disorders] | Q80169362 | ||
| Dietary carbohydrate modification induces alterations in gene expression in abdominal subcutaneous adipose tissue in persons with the metabolic syndrome: the FUNGENUT Study | Q80301537 | ||
| Nutrigenomics and gut health | Q80477170 | ||
| Interleukin-8 and -10 gene polymorphisms in irritable bowel syndrome | Q84475333 | ||
| NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses | Q24670080 | ||
| Cytokine gene polymorphisms are associated with irritable bowel syndrome: a systematic review and meta-analysis | Q27011652 | ||
| Validation of symptom-based diagnostic criteria for irritable bowel syndrome: a critical review | Q27687488 | ||
| MicroRNA gene expression deregulation in human breast cancer | Q27860690 | ||
| Modulation of hepatitis C virus RNA abundance by a liver-specific MicroRNA | Q27861124 | ||
| Pharmacogenetic trial of a cannabinoid agonist shows reduced fasting colonic motility in patients with nonconstipated irritable bowel syndrome | Q28244460 | ||
| Postprandial plasma 5-hydroxytryptamine in diarrhoea predominant irritable bowel syndrome: a pilot study | Q28379389 | ||
| The widespread impact of mammalian MicroRNAs on mRNA repression and evolution | Q29547173 | ||
| Effect of in utero and early-life conditions on adult health and disease | Q29615797 | ||
| Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection | Q29615959 | ||
| MicroRNA profiling of multiple sclerosis lesions identifies modulators of the regulatory protein CD47. | Q30937357 | ||
| Tryptophan degradation in irritable bowel syndrome: evidence of indoleamine 2,3-dioxygenase activation in a male cohort | Q33401111 | ||
| The low FODMAP diet improves gastrointestinal symptoms in patients with irritable bowel syndrome: a prospective study. | Q33458071 | ||
| Scope of the problem of functional digestive disorders | Q33535692 | ||
| The relationship between the val158met catechol-O-methyltransferase (COMT) polymorphism and irritable bowel syndrome | Q33855618 | ||
| Current insights in to the pathophysiology of Irritable Bowel Syndrome | Q33875272 | ||
| MicroRNA-29a regulates intestinal membrane permeability in patients with irritable bowel syndrome | Q33939639 | ||
| COMT val158met genotype affects mu-opioid neurotransmitter responses to a pain stressor | Q33964426 | ||
| A diet low in FODMAPs reduces symptoms of irritable bowel syndrome | Q34038352 | ||
| Meta-analysis: do irritable bowel syndrome symptoms vary between men and women? | Q34101503 | ||
| The serotonin transporter polymorphism rs25531 is associated with irritable bowel syndrome | Q34118117 | ||
| Food: the forgotten factor in the irritable bowel syndrome | Q34165614 | ||
| A microRNA regulon that mediates endothelial recruitment and metastasis by cancer cells | Q34240754 | ||
| Corticotropin-releasing hormone receptor 1 gene variants in irritable bowel syndrome | Q34407924 | ||
| S100A expression and interleukin-10 polymorphisms are associated with ulcerative colitis and diarrhea predominant irritable bowel syndrome | Q34675807 | ||
| The social environment and the epigenome | Q34728015 | ||
| First evidence for an association of a functional variant in the microRNA-510 target site of the serotonin receptor-type 3E gene with diarrhea predominant irritable bowel syndrome | Q34794063 | ||
| Not really identical: epigenetic differences in monozygotic twins and implications for twin studies in psychiatry. | Q34976672 | ||
| MicroRNAs as a target for novel antipsychotics: a systematic review of an emerging field. | Q35009094 | ||
| Association of distinct alpha(2) adrenoceptor and serotonin transporter polymorphisms with constipation and somatic symptoms in functional gastrointestinal disorders | Q35596567 | ||
| Association between a functional polymorphism in the serotonin transporter gene and diarrhoea predominant irritable bowel syndrome in women | Q35596886 | ||
| Inhibition of miR-33a/b in non-human primates raises plasma HDL and lowers VLDL triglycerides. | Q35606800 | ||
| Nutritional genomics in practice: where do we begin? | Q36084681 | ||
| Diet and rheumatoid arthritis: a review of the literature | Q36272337 | ||
| The genetics of irritable bowel syndrome | Q36306788 | ||
| Cannabinoid receptor 1 gene and irritable bowel syndrome: phenotype and quantitative traits | Q36699687 | ||
| Role of corticotropin-releasing hormone in irritable bowel syndrome and intestinal inflammation | Q36713065 | ||
| Mechanisms of disease: genetics of functional gastrointestinal disorders--searching the genes that matter | Q36724686 | ||
| Genetic association of miRNA-146a with systemic lupus erythematosus in Europeans through decreased expression of the gene. | Q36806427 | ||
| Understanding diet-gene interactions: lessons from studying nutrigenomics and cardiovascular disease | Q36842945 | ||
| Noncoding RNAs and RNA editing in brain development, functional diversification, and neurological disease | Q36872209 | ||
| Gene regulation by transcription factors and microRNAs | Q37120107 | ||
| Randomized pharmacodynamic and pharmacogenetic trial of dronabinol effects on colon transit in irritable bowel syndrome-diarrhea | Q37178858 | ||
| Epigenetics and the nervous system | Q37358217 | ||
| Childhood trauma is associated with hypothalamic-pituitary-adrenal axis responsiveness in irritable bowel syndrome | Q37463817 | ||
| The role of 5-HTT LPR and GNβ3 825C>T polymorphisms and gene-environment interactions in irritable bowel syndrome (IBS). | Q37551099 | ||
| Irritable bowel syndrome: towards biomarker identification | Q37610606 | ||
| Irritable bowel syndrome: role of food in pathogenesis and management | Q37631094 | ||
| Nutrigenomics and nutrigenetics in inflammatory bowel diseases | Q38039955 | ||
| Does our food (environment) change our gut microbiome ('in-vironment'): a potential role for inflammatory bowel disease? | Q38072222 | ||
| A microRNA-21 surge facilitates rapid cyclin D1 translation and cell cycle progression in mouse liver regeneration | Q38327797 | ||
| Investigation of interleukin-10 promoter polymorphisms and interleukin-10 levels in children with irritable bowel syndrome. | Q38447499 | ||
| Food allergy, coeliac disease and chronic inflammatory bowel disease in man. | Q38550768 | ||
| The association of serotonin transporter genetic polymorphisms and irritable bowel syndrome and its influence on tegaserod treatment in Chinese patients | Q39337639 | ||
| MiR-155 is a liposarcoma oncogene that targets casein kinase-1α and enhances β-catenin signaling | Q39393414 | ||
| Interleukin 10 genotypes in irritable bowel syndrome: evidence for an inflammatory component? | Q41967732 | ||
| Proinflammatory cytokine gene polymorphisms in irritable bowel syndrome | Q43257867 | ||
| Neonatal maternal separation alters stress-induced responses to viscerosomatic nociceptive stimuli in rat. | Q43350989 | ||
| Effects of an alpha(2)-adrenergic agonist on gastrointestinal transit, colonic motility, and sensation in humans | Q43797541 | ||
| 5-HTTLPR and STin2 polymorphisms in the serotonin transporter gene and irritable bowel syndrome: effect of bowel habit and sex. | Q45949217 | ||
| The impact of irritable bowel syndrome on health-related quality of life | Q46485395 | ||
| The relationship between somatisation and outcome in patients with severe irritable bowel syndrome | Q46577384 | ||
| Neonatal maternal separation causes colonic dysfunction in rat pups including impaired host resistance | Q46834985 | ||
| Gender difference in association between polymorphism of serotonin transporter gene regulatory region and anxiety | Q46869986 | ||
| Altered 5-hydroxytryptamine signaling in patients with constipation- and diarrhea-predominant irritable bowel syndrome | Q46885942 | ||
| Hypothalamic-pituitary-gut axis dysregulation in irritable bowel syndrome: plasma cytokines as a potential biomarker? | Q46939907 | ||
| Relationship of SERT polymorphisms to depressive and anxiety symptoms in irritable bowel syndrome | Q46972024 | ||
| Epigenetic mechanisms of perinatal programming of hypothalamic-pituitary-adrenal function and health | Q48148288 | ||
| IBS: An epigenetic perspective | Q48149173 | ||
| Association of alpha 2A adrenergic receptor gene (ADRAlpha2A) polymorphism with irritable bowel syndrome, microscopic and ulcerative colitis. | Q51804602 | ||
| Cannabinoid receptor 1 gene polymorphism and irritable bowel syndrome in the Korean population: a hypothesis-generating study. | Q53469661 | ||
| G protein beta3 subunit, interleukin-10, and tumor necrosis factor-alpha gene polymorphisms in Koreans with irritable bowel syndrome. | Q53476178 | ||
| T-Helper 1, T-Helper 2, and T-Regulatory Cytokines Gene Polymorphisms in Irritable Bowel Syndrome | Q59635752 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 376-383 | |
| P577 | publication date | 2014-01-01 | |
| P1433 | published in | World Journal of Gastroenterology | Q15708885 |
| P1476 | title | Molecular basis of the irritable bowel syndrome | |
| P478 | volume | 20 |
| Q26998380 | Epigenetic regulation of persistent pain |
| Q35847101 | Gut Microbiota Dysbiosis as Risk and Premorbid Factors of IBD and IBS Along the Childhood-Adulthood Transition |
| Q92814756 | Irritable Bowel Syndrome between Molecular Approach and Clinical Expertise-Searching for Gap Fillers in the Oxidative Stress Way of Thinking |
| Q31093698 | Neuroimaging the brain-gut axis in patients with irritable bowel syndrome |
| Q41087764 | Preinduction of heat shock protein 70 protects mice against post-infection irritable bowel syndrome via NF-κB and NOS/NO signaling pathways |
| Q22001077 | The relationship between irritable bowel syndrome and psychiatric disorders: from molecular changes to clinical manifestations |
Search more.